OKYO Pharma (OKYO) Current Assets (2021 - 2026)

OKYO Pharma (OKYO) has reported Current Assets for 6 consecutive years, with $21.0 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Current Assets rose 470.57% year-over-year to $21.0 million in Q1 2026; TTM through Mar 2026 was $21.0 million, a 470.57% increase from a year earlier, with the FY2026 full-year figure at $21.0 million, up 470.57% from the prior year.
• Current Assets was $21.0 million for Q1 2026 at OKYO Pharma, up from $4.6 million in the prior quarter.
• Over five years, Current Assets peaked at $4295.4 billion in Q1 2022 and troughed at $1.5 million in Q1 2024.
• A 5-year average of $536.9 billion and a median of $4.2 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets tumbled 100.0% in 2023 and soared 470.57% in 2026, its largest moves.
• Over 5 years, Current Assets stood at $4295.4 billion in 2022, then plunged by 100.0% to $2.4 million in 2023, then climbed by 19.17% to $2.8 million in 2024, then jumped by 64.24% to $4.6 million in 2025, then soared by 351.68% to $21.0 million in 2026.
• The last three Current Assets figures came in at $21.0 million (Q1 2026), $4.6 million (Q3 2025), and $3.7 million (Q1 2025), per Business Quant data.